![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SAMD4A |
Gene summary for SAMD4A |
![]() |
Gene information | Species | Human | Gene symbol | SAMD4A | Gene ID | 23034 |
Gene name | sterile alpha motif domain containing 4A | |
Gene Alias | SAMD4 | |
Cytomap | 14q22.2 | |
Gene Type | protein-coding | GO ID | GO:0000288 | UniProtAcc | Q9UPU9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23034 | SAMD4A | AEH-subject1 | Human | Endometrium | AEH | 1.60e-06 | 2.54e-01 | -0.3059 |
23034 | SAMD4A | AEH-subject2 | Human | Endometrium | AEH | 1.74e-04 | 2.49e-01 | -0.2525 |
23034 | SAMD4A | AEH-subject4 | Human | Endometrium | AEH | 7.57e-11 | 5.15e-01 | -0.2657 |
23034 | SAMD4A | EEC-subject1 | Human | Endometrium | EEC | 4.65e-18 | 6.21e-01 | -0.2682 |
23034 | SAMD4A | EEC-subject2 | Human | Endometrium | EEC | 1.96e-05 | 2.71e-01 | -0.2607 |
23034 | SAMD4A | EEC-subject3 | Human | Endometrium | EEC | 5.82e-10 | 4.87e-01 | -0.2525 |
23034 | SAMD4A | GSM5276934 | Human | Endometrium | EEC | 2.97e-09 | 3.77e-01 | -0.0913 |
23034 | SAMD4A | GSM5276937 | Human | Endometrium | EEC | 5.91e-08 | 3.42e-01 | -0.0897 |
23034 | SAMD4A | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 2.15e-04 | -3.42e-02 | -0.1883 |
23034 | SAMD4A | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 3.29e-02 | -7.43e-02 | -0.1917 |
23034 | SAMD4A | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 1.73e-02 | -7.43e-02 | -0.1916 |
23034 | SAMD4A | TD9 | Human | Lung | IAC | 1.99e-06 | 7.63e-01 | 0.088 |
23034 | SAMD4A | RNA-P10T2-P10T2-1 | Human | Lung | AAH | 1.77e-08 | 1.09e+00 | -0.1271 |
23034 | SAMD4A | RNA-P10T2-P10T2-2 | Human | Lung | AAH | 1.77e-08 | 9.54e-01 | -0.1406 |
23034 | SAMD4A | RNA-P10T2-P10T2-3 | Human | Lung | AAH | 2.77e-05 | 7.25e-01 | -0.1408 |
23034 | SAMD4A | RNA-P10T2-P10T2-4 | Human | Lung | AAH | 8.52e-06 | 8.28e-01 | -0.138 |
23034 | SAMD4A | RNA-P17T-P17T-2 | Human | Lung | IAC | 1.99e-06 | 8.11e-01 | 0.3371 |
23034 | SAMD4A | RNA-P17T-P17T-4 | Human | Lung | IAC | 5.52e-10 | 1.03e+00 | 0.343 |
23034 | SAMD4A | RNA-P17T-P17T-6 | Human | Lung | IAC | 1.13e-06 | 8.32e-01 | 0.3385 |
23034 | SAMD4A | RNA-P17T-P17T-8 | Human | Lung | IAC | 5.26e-09 | 8.28e-01 | 0.3329 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:190331110 | Endometrium | AEH | regulation of mRNA metabolic process | 77/2100 | 288/18723 | 1.69e-13 | 4.40e-11 | 77 |
GO:000989616 | Endometrium | AEH | positive regulation of catabolic process | 104/2100 | 492/18723 | 9.38e-11 | 1.10e-08 | 104 |
GO:003133116 | Endometrium | AEH | positive regulation of cellular catabolic process | 91/2100 | 427/18723 | 9.15e-10 | 8.31e-08 | 91 |
GO:000640210 | Endometrium | AEH | mRNA catabolic process | 59/2100 | 232/18723 | 9.51e-10 | 8.52e-08 | 59 |
GO:000641716 | Endometrium | AEH | regulation of translation | 94/2100 | 468/18723 | 1.14e-08 | 7.62e-07 | 94 |
GO:000640110 | Endometrium | AEH | RNA catabolic process | 63/2100 | 278/18723 | 3.28e-08 | 1.87e-06 | 63 |
GO:004572715 | Endometrium | AEH | positive regulation of translation | 38/2100 | 136/18723 | 6.37e-08 | 3.38e-06 | 38 |
GO:003425015 | Endometrium | AEH | positive regulation of cellular amide metabolic process | 42/2100 | 162/18723 | 1.35e-07 | 6.12e-06 | 42 |
GO:006101310 | Endometrium | AEH | regulation of mRNA catabolic process | 39/2100 | 166/18723 | 5.21e-06 | 1.33e-04 | 39 |
GO:004348810 | Endometrium | AEH | regulation of mRNA stability | 37/2100 | 158/18723 | 9.73e-06 | 2.24e-04 | 37 |
GO:19033137 | Endometrium | AEH | positive regulation of mRNA metabolic process | 30/2100 | 118/18723 | 1.21e-05 | 2.68e-04 | 30 |
GO:003465510 | Endometrium | AEH | nucleobase-containing compound catabolic process | 74/2100 | 407/18723 | 1.78e-05 | 3.65e-04 | 74 |
GO:004427010 | Endometrium | AEH | cellular nitrogen compound catabolic process | 80/2100 | 451/18723 | 2.09e-05 | 4.13e-04 | 80 |
GO:00467009 | Endometrium | AEH | heterocycle catabolic process | 79/2100 | 445/18723 | 2.27e-05 | 4.35e-04 | 79 |
GO:004348710 | Endometrium | AEH | regulation of RNA stability | 38/2100 | 170/18723 | 2.30e-05 | 4.38e-04 | 38 |
GO:00194399 | Endometrium | AEH | aromatic compound catabolic process | 80/2100 | 467/18723 | 7.21e-05 | 1.10e-03 | 80 |
GO:19013619 | Endometrium | AEH | organic cyclic compound catabolic process | 83/2100 | 495/18723 | 1.13e-04 | 1.60e-03 | 83 |
GO:00009568 | Endometrium | AEH | nuclear-transcribed mRNA catabolic process | 26/2100 | 112/18723 | 2.25e-04 | 2.75e-03 | 26 |
GO:00002897 | Endometrium | AEH | nuclear-transcribed mRNA poly(A) tail shortening | 10/2100 | 29/18723 | 8.25e-04 | 7.72e-03 | 10 |
GO:00610147 | Endometrium | AEH | positive regulation of mRNA catabolic process | 20/2100 | 87/18723 | 1.30e-03 | 1.11e-02 | 20 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SAMD4A | SNV | Missense_Mutation | novel | c.418N>T | p.Arg140Cys | p.R140C | Q9UPU9 | protein_coding | deleterious(0) | probably_damaging(0.926) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
SAMD4A | SNV | Missense_Mutation | novel | c.1744C>T | p.Pro582Ser | p.P582S | Q9UPU9 | protein_coding | deleterious(0.01) | benign(0.209) | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SAMD4A | insertion | Frame_Shift_Ins | novel | c.544_545insCT | p.Asn182ThrfsTer69 | p.N182Tfs*69 | Q9UPU9 | protein_coding | TCGA-B5-A11I-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Chemotherapy | paclitaxel | PD | ||
SAMD4A | SNV | Missense_Mutation | novel | c.149C>G | p.Ala50Gly | p.A50G | Q9UPU9 | protein_coding | tolerated(0.08) | benign(0.186) | TCGA-2Y-A9H4-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SAMD4A | SNV | Missense_Mutation | c.1085C>G | p.Ala362Gly | p.A362G | Q9UPU9 | protein_coding | deleterious(0.01) | possibly_damaging(0.869) | TCGA-DD-AADO-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SAMD4A | SNV | Missense_Mutation | novel | c.1643N>C | p.Gln548Pro | p.Q548P | Q9UPU9 | protein_coding | deleterious(0) | possibly_damaging(0.649) | TCGA-55-6969-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SAMD4A | SNV | Missense_Mutation | c.1170G>T | p.Leu390Phe | p.L390F | Q9UPU9 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-55-7903-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SAMD4A | SNV | Missense_Mutation | novel | c.2126N>T | p.Gly709Val | p.G709V | Q9UPU9 | protein_coding | deleterious(0) | possibly_damaging(0.691) | TCGA-69-7974-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
SAMD4A | SNV | Missense_Mutation | c.1527G>T | p.Leu509Phe | p.L509F | Q9UPU9 | protein_coding | deleterious(0) | possibly_damaging(0.804) | TCGA-91-6828-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SAMD4A | SNV | Missense_Mutation | novel | c.1556N>T | p.Ser519Ile | p.S519I | Q9UPU9 | protein_coding | deleterious(0) | benign(0.034) | TCGA-95-7043-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |